Interactions between normal human fibroblasts and human prostate cancer cells in a co-culture system

Anticancer Research

Volumn 32, Issue 5, 2012, Pages 1579-1588

  Iacopino, Fortunata ^a   Angelucci, Cristiana ^a   Sica, Gigliola ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Androgen insensitive cells; Androgen sensitive cells; Cell growth; Co culture; DU 145; E cadherin; FG cell lines; Fibroblasts; LNCaP; PC 3; Prostate cancer cells

Indexed keywords

UVOMORULIN;

ARTICLE; CANCER CELL; CELL COUNT; CELL GROWTH; CELL INTERACTION; CELL LINE; CELL PROLIFERATION; CELL STRUCTURE; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; FIBROBLAST; GINGIVA; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MONOLAYER CULTURE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION;

CADHERINS; CELL COMMUNICATION; CELL LINE; CELL PROLIFERATION; COCULTURE TECHNIQUES; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROSTATIC NEOPLASMS;

EID: 84861490508     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Condon MS: The role of the stromal microenvironment in prostate cancer. Semin Cancer Biol 15: 132-137, 2005.
2. Beacham DA and Cukierman E: Stromagenesis: the changing face of fibroblastic microenvironments during tumor progression. Semin Cancer Biol 15: 329-341, 2005. (Pubitemid 41140303)
3. Kalluri R and Weinberg RA: The basics of epithelial-mesenchymal transition. J Clin Invest 119: 1420-1428, 2009.
4. Niu YN and Xia SJ: Stroma-epithelium crosstalk in prostate cancer. Asian J Androl 11: 28-35, 2009.
5. Coulson-Thomas VJ, Gesteira TF, Coulson-Thomas YM, Vicente CM, Tersariol IL, Nader HB and Toma L: Fibroblast and prostate tumor cell cross-talk: fibroblast differentiation, TGF-β, and extracellular matrix down-regulation. Exp Cell Res 316: 3207-26, 2010.
6. Thalmann GN, Rhee H, Sikes RA, Pathak S, Multani A, Zhau HE, Marshall FF and Chung LW: Human prostate fibroblasts induce growth and confer castration resistance and metastatic potential in LNCaP cells. Eur Urol 58: 162-171, 2010.
7. Miki Y, Ono K, Hata S, Suzuki T, Kumamoto H and Sasano H: The advantages of co-culture over mono cell culture in simulating in vivo environment. J Steroid Biochem Mol Biol 2012 Jan 9. [Epub ahead of print]
8. Wong T, McGrath JA and Navsaria H: The role of fibroblasts in tissue engineering and regeneration. Br J Dermatol 156: 1149-1155, 2007. (Pubitemid 47029846)
9. Kalluri R and Zeisberg M: Fibroblasts in cancer. Nat Rev Cancer 6: 392-401, 2006.
10. Rubin H: Contact interactions between cells that suppress neoplastic development: Can they also explain metastatic dormancy? Adv Cancer Res 100: 159-202, 2008.
11. Yilmaz M and Christofori G: EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 28: 15-33, 2009.
12. De Wever O and Mareel M: Role of tissue stroma in cancer cell invasion. J Pathol 200: 429-447, 2003. (Pubitemid 36818244)
13. Li X, Placencio V, Iturregui JM, Uwamariya C, Sharif-Afshar AR, Koyama T, Hayward SW and Bhowmick NA: Prostate tumor progression is mediated by a paracrine TGF-beta/Wnt3a signaling axis. Oncogene 27: 7118-7130, 2008.
14. Rak J, Milsom C, Magnus N and Yu J: Tissue factor in tumour progression. Best Pract Res Clin Haematol 22: 71-83, 2009.
15. Lyons LS, Rao S, Balkan W, Faysal J, Maiorino CA and Burnstein KL: Ligand-independent activation of androgen receptors by Rho GTPase signaling in prostate cancer. Mol Endocrinol 22: 597-608, 2008. (Pubitemid 351397788)
16. Gumbiner BM: Regulation of cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Biol 6: 622-634, 2005.
17. Mǎ;rgineanu E, Cotrutz CE and Cotrutz C: Correlation between E-cadherin abnormal expressions in different types of cancer and the process of metastasis. Rev Med Chir Soc Med Nat Iasi 112: 432-436, 2008.
18. Gravdal K, Halvorsen OJ, Haukaas SA and Akslen LA: A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer. Clin Cancer Res 13: 7003-7011, 2007. (Pubitemid 350276881)
19. Jaggi M, Nazemi T, Abrahams NA, Baker JJ, Galich A, Smith LM and Balaji KC: N-cadherin switching occurs in high Gleason grade prostate cancer. Prostate 66: 193-199, 2006. (Pubitemid 43191240)
20. Fernández-Martínez AB, Bajo AM, Sánchez-Chapado M, Prieto JC and Carmena MJ: Vasoactive intestinal peptide behaves as a pro-metastatic factor in human prostate cancer cells. Prostate 69: 774-786, 2009.
21. Joyce JA and Pollard JW: Microenvironmental regulation of metastasis. Nat Rev Cancer 9: 239-252, 2009.
22. Bonfil RD, Chinni S, Fridman R, Kim HR and Cher ML: Proteases, growth factors, chemokines, and the microenvironment in prostate cancer bone metastasis. Urol Oncol 25: 407-411, 2007. (Pubitemid 47362762)
23. Mueller MM and Fusenig NE: Friends or foes-bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4: 839-849, 2004. (Pubitemid 39472951)
24. Räsänen K, Virtanen I, Salmenperä P, Grenman R and Vaheri A. Differences in the nemosis response of normal and cancerassociated fibroblasts from patients with oral squamous cell carcinoma. PLoS One 4: e6879, 2009.
25. Angeli F, Koumakis G, Chen MC, Kumar S and Delinassios JG: Role of stromal fibroblasts in cancer: Promoting or impeding? Tumour Biol 30: 109-120, 2009.
26. Proia DA and Kuperwasser C: Stroma: tumor agonist or antagonist. Cell Cycle 4: 1022-1025, 2005. (Pubitemid 41365355)
27. De Wever O, Demetter P, Mareel M and Bracke M: Stromal myofibroblasts are drivers of invasive cancer growth. Int J Cancer 123: 2229-2238, 2008.
28. Giuliani M, Camaioni D, Iacopino F, Sica G and Miani C: Effetto di farmaci calcio-antagonisti su colture di fibroblasti umani. 79th Annual World Dental Congress of FDI, Milano 1991, Monduzzi Ed., Bologna, Italy, pp. 71-76, 1991.
29. Miekus K, Czernik M, Sroka J, Czyz J and Madeja Z: Contact stimulation of prostate cancer cell migration: The role of gap junctional coupling and migration stimulated by heterotypic cell-to-cell contacts in determination of metastatic phenotype of Dunning rat prostate cancer cells. Biol Cell 97: 893-903, 2005. (Pubitemid 41819307)
30. Sarna M, Wybieralska E, Miekus K, Drukala J and Madeja Z: Topographical control of prostate cancer cell migration. Mol Med Rep 2: 865-871, 2009.
31. Delinassios JG: Cytocidal effects of human fibroblasts on HeLa cells in vitro. Biol Cell 59: 69-77, 1987.
32. Samoszuk M, Tan J and Chorn G: Clonogenic growth of human breast cancer cells co-cultured in direct contact with serum-activated fibroblasts. Breast Cancer Res 7: R274-283, 2005.
33. Degeorges A, Tatoud R, Fauvel-Lafeve F, Podgorniak MP, Millot G, de Cremoux P and Calvo F: Stromal cells from human benign prostate hyperplasia produce a growth-inhibitory factor for LNCaP prostate cancer cells, identified as interleukin-6. Int J Cancer 68: 207-214, 1996. (Pubitemid 26380125)
34. Placencio VR, Sharif-Afshar AR, Li X, Huang H, Uwamariya C, Neilson EG, Shen MM, Matusik RJ, Hayward SW and Bhowmick NA: Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity. Cancer Res 68: 4709-4718, 2008.
35. Kawada M, Inoue H, Arakawa M and Ikeda D: Transforming growth factor-beta1 modulates tumor-stromal cell interactions of prostate cancer through insulin-like growth factor-I. Anticancer Res 28: 721-730, 2008. (Pubitemid 351578914)
36. Castellón E, Venegas K, Sáenz L, Contreras H and Huidobro C: Secretion of prostatic specific antigen, proliferative activity and androgen response in epithelial-stromal co-cultures from human prostate carcinoma. Int J Androl 28: 39-46, 2005. (Pubitemid 40203731)
37. Bavik C, Coleman I, Dean JP, Knudsen B, Plymate S and Nelson PS: The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms. Cancer Res 66: 794-802, 2006. (Pubitemid 43165944)
38. Wernert N, Kaminski A, Haddouti el-M and Hahne JC: Tumor-stroma interactions of metastatic prostate cancer cell lines: analyses using microarrays. Methods Mol Biol 382: 223-237, 2007.
39. Paland N, Kamer I, Kogan-Sakin I, Madar S, Goldfinger N and Rotter V: Differential influence of normal and cancer-associated fibroblasts on the growth of human epithelial cells in an in vitro cocultivation model of prostate cancer. Mol Cancer Res 7: 1212-1223, 2009.
40. Sakko AJ, Ricciardelli C, Mayne K, Tilley WD, Lebaron RG and Horsfall DJ: Versican accumulation in human prostatic fibroblast cultures is enhanced by prostate cancer cell-derived transforming growth factor beta 1. Cancer Res 61: 926-930, 2001. (Pubitemid 32174405)
41. O'Connor JC, Farach-Carson MC, Schneider CJ and Carson DD: Coculture with prostate cancer cells alters endoglin expression and attenuates transforming growth factor-beta signaling in reactive bone marrow stromal cells. Mol Cancer Res 5: 585-603, 2007. (Pubitemid 46985048)
42. Hinz B, Pittet P, Smith-Clerc J, Chaponnier C and Meister JJ: Myofibroblast development is characterized by specific cell-cell adherens junctions. Mol Biol Cell 15: 4310-4320, 2004. (Pubitemid 39122032)
43. Alonso-Magdalena P, Brössner C, Reiner A, Cheng G, Sugiyama N, Warner M and Gustafsson JA: A role for epithelialmesenchymal transition in the etiology of benign prostatic hyperplasia. Proc Natl Acad Sci USA 106: 2859-2863, 2009.
44. Karim RZ, Gerega SK, Yang YH, Horvath L, Spillane A, Carmalt H, Scolyer RA and Lee CS: Proteins from the Wnt pathway are involved in the pathogenesis and progression of mammary phyllodes tumours. J Clin Pathol 62: 1016-1020, 2009.
45. Angelucci C, Iacopino F, Ferracuti S, Urbano R and Sica G: Recombinant human IFN-beta affects androgen receptor level, neuroendocrine differentiation, cell adhesion, and motility in prostate cancer cells. J Interferon Cytokine Res 27: 643-652, 2007. (Pubitemid 350194561)
46. Mitchell S, Abel P, Ware M, Stamp G and Lalani E: Phenotypic and genotypic characterization of commonly used human prostatic cell lines. BJU Int 85: 932-944, 2000. (Pubitemid 30242804)
47. Lang SH, Hyde C, Reid IN, Hitchcock IS, Hart CA, Bryden AA, Villette JM, Stower MJ and Maitland NJ: Enhanced expression of vimentin in motile prostate cell lines and in poorly differentiated and metastatic prostate carcinoma. Prostate 52: 253-263, 2002.
48. Whitaker HC, Stanbury DP, Brinham C, Girling J, Hanrahan S, Totty N and Neal DE: Labeling and identification of LNCaP cell surface proteins: a pilot study. Prostate 67: 943-954, 2007. (Pubitemid 46828928)
49. Lang SH, Sharrard RM, Stark M, Villette JM and Maitland NJ: Prostate epithelial cell lines form spheroids with evidence of glandular differentiation in three-dimensional Matrigel cultures Br J Cancer 85: 590-599, 2001. (Pubitemid 32808286)
50. Salahshor S, Naidoo R, Serra S, Shih W, Tsao MS, Chetty R and Woodgett JR: Frequent accumulation of nuclear E-cadherin and alterations in the Wnt signaling pathway in esophageal squamous cell carcinomas. Mod Pathol 21: 271-281, 2008. (Pubitemid 351304280)
51. Gervais ML, Henry PC, Saravanan A, Burry TN, Gallie BL, Jewett MA, Hill RP, Evans AJ and Ohh M: Nuclear E-cadherin and VHL immunoreactivity are prognostic indicators of clearcell renal cell carcinoma. Lab Invest 87: 1252-1264, 2007. (Pubitemid 350126708)
52. Izumi T, Oda Y, Hasegawa T, Nakanishi Y, Kawai A, Sonobe H, Takahira T, Kobayashi C, Yamamoto H, Tamiya S, Hirohashi S, Iwamoto Y and Tsuneyoshi M: Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression. Am J Surg Pathol 31: 85-94, 2007. (Pubitemid 46036906)
53. Chetty R, Serra S and Asa SL: Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors. Am J Surg Pathol 32: 413-419, 2008. (Pubitemid 351398933)
54. Yates CC, Shepard CR, Stolz DB and Wells A: Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin. Br J Cancer 96: 1246-52, 2007. (Pubitemid 46625074)
55. Omelchenko T, Fetisova E, Ivanova O, Bonder EM, Feder H, Vasiliev JM and Gelfand IM: Contact interactions between epitheliocytes and fibroblasts: formation of heterotypic cadherincontaining adhesion sites is accompanied by local cytoskeletal reorganization. Proc Natl Acad Sci USA 98: 8632-8637, 2001. (Pubitemid 32678079)
56. Chambers KF, Pearson JF, Aziz N, O'Toole P, Garrod D and Lang SH: Stroma regulates increased epithelial lateral cell adhesion in 3D culture: a role for actin/cadherin dynamics. PLoS One 6: e18796, 2011
57. Hiscox S, Barrett-Lee P and Nicholson RI: Therapeutic targeting of tumor-stroma interactions. Expert Opin Ther Targets 15: 609-621, 2011.
58. Liu R, Li H, Liu L, Yu J and Ren X: Fibroblast activation protein: A potential therapeutic target in cancer. Cancer Biol Ther 13: 123-129, 2012.